Pharma-Bio Serv (OTCMKTS:PBSV) Releases Quarterly Earnings Results

Pharma-Bio Serv (OTCMKTS:PBSVGet Free Report) released its quarterly earnings results on Thursday. The company reported $0.02 earnings per share for the quarter, meeting the consensus estimate of $0.02, Yahoo Finance reports. Pharma-Bio Serv had a return on equity of 9.33% and a net margin of 8.49%. The firm had revenue of $4.58 million for the quarter, compared to analysts’ expectations of $5.40 million.

Pharma-Bio Serv Stock Up 8.7 %

OTCMKTS:PBSV opened at $1.00 on Friday. The business’s 50-day moving average price is $0.97 and its two-hundred day moving average price is $0.96. Pharma-Bio Serv has a twelve month low of $0.68 and a twelve month high of $1.20. The stock has a market cap of $22.98 million, a P/E ratio of 14.29 and a beta of 0.41.

Pharma-Bio Serv Company Profile

(Get Free Report)

Pharma-Bio Serv, Inc operates as a compliance and technology transfer services consulting firm in the United States and internationally. The company provides technical compliance consulting services comprising regulatory compliance, validation, technology transfer, engineering, project management, and process support to the pharmaceutical, chemical, biotechnology, medical device, cosmetic, food industries, and allied products companies.

Further Reading

Earnings History for Pharma-Bio Serv (OTCMKTS:PBSV)

Receive News & Ratings for Pharma-Bio Serv Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Pharma-Bio Serv and related companies with's FREE daily email newsletter.